Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-15-000484
Filing Date
2015-03-17
Accepted
2015-03-17 17:09:36
Documents
2
Period of Report
2015-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 6-K oncolyticsform6k.htm 6-K 15719
2 NEWS RELEASE DATED MARCH 16, 2015 ex991.htm EX-99.1 84052
  Complete submission text file 0001279569-15-000484.txt   100782
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 15707740
SIC: 2834 Pharmaceutical Preparations